Researchers developed a novel way to image inflammation in multiple sclerosis, a disease that is notoriously difficult to diagnose early.
Diagnosis of inflammatory bowel disease currently requires an invasive procedure. New research identifies a way to identify the disease using a blood draw.
A therapy delayed the onset of Type 1 diabetes in at-risk people by about two years, new results from a clinical trial show.
Speakers at Stanford's Big Data in Precision Health conference discuss how their work with big data impacts and informs sleep research.
Type 1 diabetes starts out as a sneak attack by bad-actor antibodies. But scientists at Stanford and UCSF have developed an early-warning system.
Stanford scientists have dug up a defect at the heart of rheumatoid arthritis: a faulty "anchor" that should be tethering a key molecule to the spot inside immune cells where it has to be in order to do its job. It seems this defect can be reversed with a not yet commercially available small-molecule drug.
A Stanford medicine patient regains quality of life after receiving treatment for his rare inflammatory esophagus condition.
In a video, Stanford Children's Health's Healthier, Happier Lives Blog introduces a patient with celiac disease and discusses the symptoms, diagnosis and treatment of the autoimmune disorder.
Rheumatoid arthritis and coronary artery disease share a common culprit: an important type of immune cell, called a macrophage, that has gone haywire. Stanford investigators have zeroed in on a molecular defect in macrophages' metabolic process that drives both disorders.
Researchers have identified an immune cell type with an apparently critical role in multiple sclerosis, and a way to block its entry into the brain.
A new study suggests that a blood test following exercise may be a good way to differentiate between people who have ME/CFS and people who don't.